Merck & Co (MRK)
$89.98
1.45 (1.59%)
MRK Stock Quote Delayed 30 Minutes
The 3 Most Undervalued S&P 500 Stocks to Buy in April 2024
Our economy is on the up and up, and investing is a must,. Let's review the most undervalued S&P 500 stocks to buy in April.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
227.77B
PE Ratio
18.86
EPS
4.77
Volume (Avg. Vol.)
1.84M
Day's Range
$89.65 - $91.37
52-Week Range
$81.04 - $134.63
Dividend & Yield
$3.08 (3.42%)
MRK Stock Predictions, Articles, and Merck & Co News
3 Long-Term Winners from Charles Schwab’s Top Picks
Explore the growth and resilience of long-term stocks Microsoft, Merck and Veralto in the latest Charles Schwab stocks portfolio update.
3 Pharma Stocks to Sell in February Before They Crash and Burn
The good times are coming to an end for these overpriced pharma stocks to sell this month before they crash and burn.
Why Is Evaxion Biotech (EVAX) Stock Up 30% Today?
Evaxion Biotech stock is climbing higher on Wednesday alongside news of Merck acquiring shares of EVAX for an 11.4% stake in the company.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to dive into the biggest pre-market stock movers on Tuesday with a breakdown of all the latest news affecting shares this morning.
Why Is Harpoon Therapeutics (HARP) Stock Up 111% Today?
Harpoon Therapeutics stock is rocketing higher on Monday as HARP investors react to Merck acquiring the company for $23 per share.
Why Is Moderna (MRNA) Stock Up 11% Today?
Moderna stock is on the rise Thursday as investors in MRNA react to positive results from a skin cancer vaccine in a Phase 2b trial.
Why Is C4 Therapeutics (CCCC) Stock Up 72% Today?
C4 Therapeutics stock is rising higher on Tuesday as investors in CCCC shares celebrate a new collaboration agreement with Merck.
